Hologic, Inc. (NasdaqGS:HOLX) announces a share repurchase program. Under the program, the company will repurchase up to $1,000 million worth of its outstanding common stock. The repurchase plan is valid for 5 years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.8 USD | -0.26% | -1.63% | +3.29% |
22/05 | FDA classifies recall of Hologic's implant as 'most serious' | RE |
22/05 | FDA classifies recall of Hologic's implants for soft tissue as 'most serious' | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.29% | 17.22B | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.32% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. announces an Equity Buyback for $1,000 million worth of its shares.